Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough Pain
NCT00236093
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Pain
Cancer
Sickle Cell Anemia
Severe Burns
Interventions
DRUG:
ACTIQ (Oral Transmucosal Fentanyl Citrate [OTFC])
Sponsor
Cephalon